United States Coagulation Albumin Market Report: Growing Demand for Albumin and Coagulation Support Therapies in Hospitals
The United States represents a major contributor to the Coagulation Albumin Market, supported by a well-established healthcare infrastructure and a high prevalence of bleeding disorders, liver diseases, and critical care conditions. The country benefits from a strong plasma collection network, increasing adoption of plasma-derived therapies, and significant investments in biotechnology...
0 Commentarios 0 Acciones 4 Views 0 Vista previa